Pasar al contenido principal

PROPIEDADES CARDIOMETABOLICAS DE OMEGA-3 FUNCIONALIZADO CON HIDROXITIROSOL EN POBLACION SANA Y DE RIESGO

PRE2022-102252

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Formación
Convocatoria Contratos Predoctorales
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hydroxytyrosyl eicosapentaenoate as a potential antioxidant for omega-3 fatty acids: Improved synthesis and comparative evaluation with other natural antioxidants

  • García-Acosta, Natalia
  • Cert, María Rosa
  • Jordán, Marta
  • Goya, Luis
  • Mateos, Raquel
  • Espartero, José L.
This article belongs to the Section Lipids., Hydroxytyrosol (HT), the primary phenolic compound in virgin olive oil, has notable cardiovascular benefits, particularly in preventing low-density lipoprotein (LDL) oxidation. However, its hydrophilicity limits its solubility and integration into lipid-based formulations. This study aimed to enhance its lipophilicity by synthesizing hydroxytyrosyl eicosapentaenoate (HT-EPA), a derivative of HT and eicosapentaenoic acid (EPA), using a one-step enzymatic catalysis with lipase B from Candida antarctica (CALB). The reaction, performed as a suspension of HT in ethyl eicosapentaenoate (Et-EPA) (1:9 molar ratio) under vacuum, achieved higher yields and shorter reaction times than previously reported, with a purity exceeding 98%, confirmed by 1H-NMR. For the first time, the antioxidant capacity of HT-EPA in comparison with other natural antioxidants was assessed using the FRAP assay, while its oxidative stability in an omega-3-rich oil matrix was evaluated via the Rancimat method. HT-EPA and hydroxytyrosyl acetate (HT-Ac) displayed antioxidant activity comparable to HT but significantly higher than α-tocopherol, a common food antioxidant. Given the scarcity of effective lipid-soluble antioxidants, HT-EPA represents a promising candidate for omega-3 nutraceuticals, offering enhanced stability and potential health benefits. This study provides a simple, efficient, and scalable strategy for developing functional lipid-based formulations with cardioprotective potential by improving HT solubility while preserving its antioxidant properties., This research was funded by Ministerio de Ciencia, Innovación y Universidades (MICIN), and Agencia Estatal de Investigación (AEI), grant number PID2021-125259OB-I00. N.G-A and M.J. are recipients of FPI predoctoral fellowships also from MICIN/AEI (PRE2022-105658 and PRE2022-102252, respectively)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hydroxytyrosol bioavailability: Unraveling influencing factors and optimization strategies for dietary supplements

  • Jordán, Marta
  • García-Acosta, Natalia
  • Espartero, José L.
  • Goya, Luis
  • Mateos, Raquel
This article belongs to the Special Issue Phytochemicals in Foods, Plant Extracts, and Nutraceuticals, Their Bioavailability and Integral Health Effects., Hydroxytyrosol (HT) is a major phenolic compound in olives and extra virgin olive oil (EVOO), known for its antioxidant, anti-inflammatory, and cardiometabolic properties. The European Food Safety Authority (EFSA) has approved a health claim for the protection of LDL particles from oxidative damage only when HT is consumed within EVOO, which limits its direct use in supplements or functional foods. Since its biological effects depend on absorption, distribution, metabolism, and excretion (ADME), understanding how formulation and delivery strategies influence bioavailability is essential. HT is mainly present as secoiridoid derivatives in EVOO, whereas in supplements, it often appears in its free form, potentially affecting its metabolic fate. This review summarizes human studies on HT bioavailability from EVOO, isolated supplements, and enriched foods, and examines how matrix type, chemical modifications of HT, and advanced delivery systems, such as emulsions, encapsulation, and vesicular carriers, modulate absorption and metabolism. The gut microbiota is highlighted as an emerging factor in HT biotransformation, although its role remains underexplored. Further well-designed human studies are needed to guide the development of nutraceutical formulations capable of replicating the health benefits of EVOO beyond its natural matrix., This research was funded by the Ministerio de Ciencia, Innovación y Universidades (MICIN) (Spain) through project grant number PID2021-125259OB-I00. M.J. and. N.G-A are recipients of FPI predoctoral fellowships also from MICIN/AEI (PRE2022-102252 and PRE2022-105658, respectively)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Unraveling the phenolic profiles of Clinopodium bolivianum (Benth.) Kuntze and Minthostachys mollis (Benth.) Griseb.: A comprehensive LC-QtoF metabolomic study of underexplored Peruvian medicinal plants

  • García-Acosta, Natalia
  • Moratilla-Rivera, Ignacio
  • Jordán, Marta
  • Balderas, Claudia
  • Clavo, Zoyla-Mirella
  • Mateos, Raquel
The data that support the findings of this study are available on request from the corresponding author., Medicinal plants remain a primary healthcare resource worldwide, particularly in regions with strong cultural traditions and limited economic development. In Peru, muña [Minthostachys mollis (Benth.) Griseb.] and inca muña [Clinopodium bolivianum (Benth.) Kuntze], both Lamiaceae species used for gastrointestinal and anti-inflammatory purposes, are poorly characterized at the metabolomic level, limiting the availability of phytochemical data required to ensure the quality and authenticity of commercial preparations. This study aimed to unravel and comprehensively characterize the phenolic metabolomes of both species and evaluate their antioxidant capacity, providing novel chemical evidence for species differentiation assessment. The samples underwent a two-stage solid-liquid extraction, and the resulting extracts were analyzed using Folin-Ciocalteu, FRAP and ABTS assays, and extensively profiled by LC-ESI-QToF based metabolomics. Morphological characterization was performed by light microscopy. The results showed that inca muña had a higher phenolic content, expressed as milligrams of gallic acid equivalents (mg GAE) per 200 mL of infusion (201 vs. 134 mg GAE/200 mL, and superior antioxidant capacity in FRAP and ABTS assays. A total of fifty-one phenolic compounds were tentatively identified, predominantly flavonols, flavones, hydroxybenzoic acids, and hydroxycinnamic acids. Multivariate metabolomic analysis revealed distinct phenolic profiles between species, highlighting clear interspecific differences. Muña stood out for phenylacetaldehyde, galloyl sucrose, and isoflavones, while inca muña showed higher levels of cudraflavone and naringenin, proposed as potential discriminant biomarkers. Together, these findings unravel the phenolic metabolomes of two underexplored Peruvian medicinal plants, support their antioxidant potential, and provide a comprehensive metabolomic basis for chemical differentiation and paved the way to a more accurate authenticity assessment in commercial herbal preparations., This research was funded by the Ministerio de Ciencia, Innovación y Universidades (MICIN, Spain) through project grant number PID2021–125259OB-I00. Additionally, this work was supported by the Scientific Network COMETA funded by the CSIC and by the grant of Agencia Nacional de Investigación y Desarrollo (ANID, FOVI240263) from Chile. M.J. and. N.G-A are recipients of FPI predoctoral fellowships also from MICIN/AEI (PRE2022–102252 and PRE2022–105658, respectively) I.M.-R is the recipient of an FPU contract from the predoctoral program (FPU23/00141) of MICIN., Peer reviewed